Pituitary tumor size in acromegaly during pegvisomant treatment: experience 
from MR re-evaluations of the German Pegvisomant Observational Study

Buchfelder, M.; Weigel, D.; Droste, M.; Mann, K.; Saller, B.; Brubach, K.; Stalla, G. K.; Bidlingmaier, M.; Strasburger, C. J.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Pituitary tumor size in acromegaly during pegvisomant treatment: experience from MR re-evaluations of the German Pegvisomant Observational Study

MPS-Authors

Stalla, G. K.
Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Buchfelder, M., Weigel, D., Droste, M., Mann, K., Saller, B., Brubach, K., et al. (2009). Pituitary tumor size in acromegaly during pegvisomant treatment: experience from MR re-evaluations of the German Pegvisomant Observational Study. European Journal of Endocrinology, 161(1), 27-35.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-9277-D

Abstract

There is no abstract available